Strontium chloride promotes cell proliferation in a human osteoblast cell line

DSpace Repository

Strontium chloride promotes cell proliferation in a human osteoblast cell line

Show full item record

Files for download

Facebook

Simple item record

Publication Report
Title Strontium chloride promotes cell proliferation in a human osteoblast cell line
Author(s) Aidoukovitch, Alexandra ; Nebel, Daniel ; Svensson, Daniel ; Stavropoulos, Andreas ; Nilsson, Bengt-Olof
Date 2014
English abstract
Strontium ranelate (SrRan) is the active component of drugs currently used for reducing the risk of fractures in patients suffering from osteoporosis. Despite extensive use, the underlying mechanisms of action of Sr2+ are not fully understood. In the present study, we assess the impact of SrCl2 on human osteoblast activity and proliferation. Cultures of the human osteoblast-like cell line MG63 were treated for 72 h in presence of 0.1 mM, 1 mM, 5 mM and 10 mM SrCl2 or vehicle, used in control groups. Cells were counted manually using a Bürker chamber. Total protein content was determined by colorimetric analysis performed by a microplate reader using Bio-Rad protein assay. Alkaline phosphatase (ALP) activity was determined enzymatically and normalized to total protein content in each sample. Cell viability was assessed using the MTT assay. Treatment with 5 mM SrCl2 for 72 h enhanced total MG63 cell protein content by 37% compared to controls (p<0.01). A lower concentration (0.1 mM) of SrCl2 had no effect on total protein. Incubation with 5 mM SrCl2 for 72 h increased MG63 cell number by 38% compared to controls (p<0.001). The SrCl2-induced increase in cell number was associated with enhanced (+14% compared to controls, p<0.05) cell viability. Treatment with a higher concentration (10 mM) of SrCl2 enhanced cell number similar to 5 mM SrCl2 (+54% compared to controls, p<0.05). Treatment with 0.1 or 5 mM SrCl2 for 72 h had no effect (p>0.05) on MG63 cell ALP activity, while 1 mM SrCl2 reduced ALP activity as well as total protein content by about 25% compared to controls (p<0.05). The current results demonstrate that treatment with SrCl2 for 72 h, at concentrations higher than 1 mM promotes cell proliferation in human osteoblast-like cells, suggesting that Sr2+ may enhance bone formation through this mechanism.
Pages 1
Language eng (iso)
Subject(s) Alkaline Phosphatase
Cell Division/Drug effects
In vitro
Osteoblasts
Strontium
Strontium Chloride
Medicine
Research Subject Categories::ODONTOLOGY
Handle http://hdl.handle.net/2043/18060 (link to this page)

This item appears in the following Collection(s)

Show full item record

Search


Browse

My Account

Statistics